| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30K | — | — |
| R&D Expense | $11K | — | -68.8% |
| SG&A Expense | $69K | — | -42.9% |
| Operating Income | -$49K | — | +59.0% |
| Pre-tax Income | -$49K | — | +59.0% |
| Net Income | -$49K | — | +59.0% |
| EPS (Basic) | -$0.00 | — | +66.7% |
| EPS (Diluted) | -$0.00 | — | +66.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $55K | -72.6% | -63.3% |
| Total Assets | $225K | +12.9% | +51.5% |
| Current Liabilities | $66K | +466.7% | +356.6% |
| Total Liabilities | $66K | +466.7% | +356.6% |
| Stockholders' Equity | $160K | -15.0% | +19.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $13K | — | +109.2% |
| Financing Cash Flow | $19K | — | -93.5% |